Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Plos Medicine
|
October 4, 2021
Testing approaches to sharing trial results with participants: The Show RESPECT cluster randomised, factorial, mixed methods trial
Annabelle South, Nalinie Joharatnam-Hogan, Cara Purvis, et al.
BJU International
|
July 31, 2025
Preferences between three options for androgen deprivation therapy: a focus group study
Hannah L Rush, Sophie Merrick, John Marshall, et al.
Campbell Systematic Reviews
|
June 12, 2026
PROTOCOL: Comparative Effectiveness of Tools for Communicating Health Research Results to Study Participants and Others With Relevant Lived Experience: A Living Systematic Review of Randomized Controlled Trials
Elsa-Lynn Nassar, Claire E Adams, Danielle B Rice, et al.
British Journal of Haematology
|
May 6, 2021
Transfusion management of severe anaemia in African children: a consensus algorithm
Kathryn Maitland, Sarah Kiguli, Peter Olupot-Olupot, et al.
BMC Health Services Research
|
August 21, 2014
The Lablite project: a cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe
Adrienne K Chan, Deborah Ford, Harriet Namata, et al.
BMC Health Services Research
|
November 18, 2016
Shifting human resources for health in the context of ART provision: qualitative and quantitative findings from the Lablite baseline study
Misheck J Nkhata, Margaret Muzambi, Deborah Ford, et al.
Contemporary Clinical Trials
|
January 9, 2026
Trial design and enrolment characteristics of LATA (long-acting treatment in adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa
Diana Anena, Elizabeth Chappell, Rashidah Nazzinda, et al.
The Lancet. HIV
|
April 10, 2026
Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trial
Adeodata R Kekitiinwa, Angus Jennings, Mutsa Bwakura-Dangarembizi, et al.
Trials
|
September 6, 2022
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units
Sharon B Love, Fay Cafferty, Claire Snowdon, et al.
The New England Journal of Medicine
|
May 14, 2025
Second-Line Antiretroviral Therapy for Children Living with HIV in Africa
Victor Musiime, Mutsa Bwakura-Dangarembizi, Alexander J Szubert, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Plos Medicine
|
October 4, 2021
Testing approaches to sharing trial results with participants: The Show RESPECT cluster randomised, factorial, mixed methods trial
Annabelle South, Nalinie Joharatnam-Hogan, Cara Purvis, et al.
BJU International
|
July 31, 2025
Preferences between three options for androgen deprivation therapy: a focus group study
Hannah L Rush, Sophie Merrick, John Marshall, et al.
Campbell Systematic Reviews
|
June 12, 2026
PROTOCOL: Comparative Effectiveness of Tools for Communicating Health Research Results to Study Participants and Others With Relevant Lived Experience: A Living Systematic Review of Randomized Controlled Trials
Elsa-Lynn Nassar, Claire E Adams, Danielle B Rice, et al.
British Journal of Haematology
|
May 6, 2021
Transfusion management of severe anaemia in African children: a consensus algorithm
Kathryn Maitland, Sarah Kiguli, Peter Olupot-Olupot, et al.
BMC Health Services Research
|
August 21, 2014
The Lablite project: a cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe
Adrienne K Chan, Deborah Ford, Harriet Namata, et al.
BMC Health Services Research
|
November 18, 2016
Shifting human resources for health in the context of ART provision: qualitative and quantitative findings from the Lablite baseline study
Misheck J Nkhata, Margaret Muzambi, Deborah Ford, et al.
Contemporary Clinical Trials
|
January 9, 2026
Trial design and enrolment characteristics of LATA (long-acting treatment in adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa
Diana Anena, Elizabeth Chappell, Rashidah Nazzinda, et al.
The Lancet. HIV
|
April 10, 2026
Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trial
Adeodata R Kekitiinwa, Angus Jennings, Mutsa Bwakura-Dangarembizi, et al.
Trials
|
September 6, 2022
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units
Sharon B Love, Fay Cafferty, Claire Snowdon, et al.
The New England Journal of Medicine
|
May 14, 2025
Second-Line Antiretroviral Therapy for Children Living with HIV in Africa
Victor Musiime, Mutsa Bwakura-Dangarembizi, Alexander J Szubert, et al.
Page
of 4